PALLEIKO BENJAMIN L (CFO and Secretary) sold 1.5% of their position (6.69K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $107.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/10/2026ACC: 0001366244-26-000005
Officer· CFO and Secretary
Since Sep 2018
-6.69K
Net shares
Net seller
$107.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15.63K acquired · 22.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15.63K
Price / share
—
Trade value
—
% of position
3.5%
3/6/2026
442.88K→458.51K
Common Stock
Direct
Shares
−6.69K
Price / share
$16.08
Trade value
$107.63K
% of position
1.5%
3/9/2026
458.51K→451.81K
Total
Net shares
+8.93K
Net value
-$107.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | M · Option Exercise | +15.63K | — | — | 3.5% | 442.88K | 458.51K |
| Common Stock Direct | 3/9/2026 | S · Sale | −6.69K | $16.08 | $107.63K | 1.5% | 458.51K | 451.81K |
| Total | +8.93K | -$107.63K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
15.63K shares
Shares
−15.63K
Strike price
Held after
125K
Exercisable
—
3/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock15.63K shares | 3/6/2026 | M · Option Exercise | −15.63K | — | 125K |